Are carcinogens electron acceptors? A novel hypothesis.
Carcinogeneses
Electron acceptors
Epigenetic pathway
Hypotheses
Metabolic stress
Journal
Medical hypotheses
ISSN: 1532-2777
Titre abrégé: Med Hypotheses
Pays: United States
ID NLM: 7505668
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
18
07
2020
revised:
27
07
2020
accepted:
28
08
2020
pubmed:
18
11
2020
medline:
15
5
2021
entrez:
17
11
2020
Statut:
ppublish
Résumé
Carcinogens play a key role in cancer initiation. Conventional theories support the concept of genetic changes inducing tumorigenesis through proteomics and metabolomics which lead to cancer development. Current research provides evidence that metabolic genes may be altered long before mutation of tumour suppressor genes, strongly suggesting that metabolic changes may be preceding the changes seen at a genetic level. Since cancer has long been known to occur through gene regulation, an impaired cellular respiration without utilizing mitochondrial function has been an area of active interest. We hypothesize the activity of carcinogens as electron acceptors to disrupt the normal glycolysis cycle happening in a cell by acting as positive ligands. The continuous restoration of NAD+ to cytosol by oxidation of NADH with carcinogen as electron acceptor creates a metabolic pathway to assist in the carcinogenic process. This metabolic pathway continues through an adaptive process, supplemented by pyruvate converting to lactate providing a constant pool of NAD+ to continue the glycolytic pathway. We also hypothesize that carcinogenesis occurs as a precursor to metabolic stress which may promote altered genetic and protein expression causing aberrant epigenetic and cell signaling pathways.
Identifiants
pubmed: 33201802
pii: S0306-9877(20)32293-3
doi: 10.1016/j.mehy.2020.110235
pii:
doi:
Substances chimiques
Carcinogens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110235Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.